NATI - National Instruments gains as Emerson deal filed under simplified procedure in China

2023-07-26 11:01:30 ET

National Instruments ( NASDAQ: NATI ) rose 1.7% after its planned sale to Emerson Electric ( NYSE: EMR ) was filed under a simplified procedure in China.

The $8.2 billion sale to Emerson ( EMR ) was filed under simplified procedure with China's main antitrust regulator, the State Administration for Market Regulation, according to a filing on the regulator's website on Wednesday.

National Instruments ( NATI ) also gained 2.8% on Tuesday amid a report that the transaction was filed under simplified procedure in China.

There have been reports in recent months that there may be concerns about the deal's possible impact on NATI's ability to continue to supply the Chinese market, especially with recent export control rules.

Emerson ( EMR ) agreed to buy National Instruments ( NATI ), a maker of industrial electronics , for $60 a share in cash for a total value of $8.2 billion in April.

National Instruments' ( NATI ) shares may also be moving in sympathy after the Chinese antitrust regulator conditionally approved MaxLinear's ( MXL ) $3.8 billion purchase of Silicon Motion (SIMO ), sending SIMO shares surging 77% as it took some investors by surprise.

More on National Instruments/Silicon Motion

• China weighs Emerson's filing for National Instruments under simplified procedure -report
• National Instruments' M&A Deal: Little Risk, And Acceptable Spread
• National Instruments shareholders approve proposed acquisition by Emerson

For further details see: